Successful treatment of shrinking lung syndrome with rituximab in a patient with systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 16, Issue 2, 2010, Pages 68-70

  Benham, Helen ^a   Garske, Luke ^b   Vecchio, Phillip ^a   Eckert, B W ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Rituximab; Shrinking lung syndrome; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID; NARCOTIC ANALGESIC AGENT; PREDNISONE; RITUXIMAB;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE ESCALATION; DRUG MEGADOSE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; HUMAN; KIDNEY FUNCTION; LUNG DISEASE; LUNG FUNCTION TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; SHRINKING LUNG SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; REMISSION INDUCTION; SYNDROME;

EID: 77949449555     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181d0757f     Document Type: Article

References (16)

1. Hoffbrand BI, Beck ER. Unexplained dyspnea and shrinking lung in systemic lupus erythematosus. Br Med J. 1965;1:1273-1277.
2. Laroche CM, Mulvey DA, Hawkins PN, et al.. Diaphragm strength in the shrinking lung syndrome in systemic lupus erythematosus. Q J Med. 1989; 71:429-439.
3. Oud KT, Bresser P, Ten Berge RJ, et al.. The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroids. Lupus. 2005;14:959-963.
4. Walz-Leblanc BA, Urowitz MB, Gladman DD, et al.. Shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy. J Rheumatol. 1992;19:1970-1972.
5. Warrington KJ, Moder KG, Brutinel WM, et al.. Shrinking lung syndrome in systemic lupus erythematosus. Mayo Clin Proc. 2000;75:467-472.
6. Thompson PJ, Dhillon DP, Ledingham J, et al.. Shrinking lungs, diaphragmatic dysfunction and systemic lupus erythematosus. Am Rev Respir Dis. 1985;132:926-928.
7. Munoz-Rodriguez FJ, Font J, Badia JR, et al.. Shrinking lung syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist. Lupus. 1997;6:412-414.
8. Van Veen S, Peters AJ, Sterk PJ, et al.. Shrinking lung syndrome in SLE, treatment with theophylline. Clin Rheumatol. 1993;12:462-465.
9. Vigna-Perez M, Hernandez-Castro B, Paredes-Saharopulos O, et al.. Clinical and immunological effects of Rituximab in lupus nephritis refractory to conventional therapy: a pilot study. Arthritis Res Ther. 2006;8:R83.
10. Ring T, Kallenbach M, Praetorius J, et al.. Successful treatment of Sjrogren's syndrome with Rituximab. Clin Rheumatol. 2006;25:891-894.
11. Branger S, Schleinitz N, Gayet S, et al.. Shrinking lung syndrome and systemic autoimmune disease in French. Rev Med Interne. 2004;25:83-90.
12. Edwards JC, Szczepanski L, Szechinski J, et al.. Efficacy of B-cell targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350:2572-2581.
13. Looney RJ, Anolik J, Sanz I. B cells as therapeutic targets for rheumatic diseases. Curr Opin Rheumatol. 2004;16:180-185.
14. Smith KG, Jones RB, Burns SM, et al.. Long-term comparison of Rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum. 2006;54:2970-2982.
15. Toya SP, Tzelepis GE. Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: a systematic review. Semin Arthritis. 2009;39:30-37.
16. Vilaplana-Garcia R, Trujillo-Santos AJ, Vera-Mendez FJ. Shrinking lung syndrome: a rare manifestation of systemic lupus erythematosus in Spanish. Arch Bronconeumol. 2008;44:341-342.